A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

Search Archive

It’s Time For An Official Social Media Policy

Posted by | 11:49am on Thursday, May 19, 2016 | No Comments
Time for a Social Media Policy

Social media has been nothing short of a challenge in the pharmaceutical space from both a presence and advertising standpoint.  Manufacturers know that it makes sense but it has been difficult to be active when the advertising guidelines put out by the FDA are confusing, unclear, and sometimes just plain inaccurate.  Making matters worse and the guidelines even more suspect was the fact that the FDA was one of the few government agencies that didn’t even have its own social media policy.

All that changed in the middle of November (of 2015) when the FDA released its own policy on using social media.  This policy focused only on using social media and not advertising.  But it’s well thought out and a great benchmark when crafting your own policy.  That being said, it’s about time you think about developing your own social media policy.

Here are 5 points to think about when determining your own policy:

  • How do you plan to use social media?  To build community and encourage engagement, for marketing purposes, customer service or all of the above?
  • What social media channels do you plan to have a presence on?  Where are your patients or people you are targeting spending time?  Are they active on Facebook, twitter, Instagram, etc.?
  • What are all your consumer, patient, member touchpoints and who in your company currently interacts with these people in some way?
  • Who can post on behalf of the company on its respective social media properties?  How will engagement and questions be managed?  Related to this is that it’s imperative to define a social media content strategy from the onset.
  • Will you encourage employees to participate in social media or “try” to stymie personal use (no easy task)?  Consider providing guidelines for those who decide to participate such as a disclaimer indicating that the views are personal, conduct oneself in a mature/professional manner at all times, not disclosing information only privately available, etc.

While you’re crafting a social media policy, I’d suggest thinking about your entire social media presence too.  Given the way social media channels work, you will most likely need to advertise in order to be able to reach your target.  Even though the latest FDA Social Guidance is very general at best and includes some inaccurate suggestions at worst, it still provides parameters that should be adhered to when advertising via social media in the pharmaceutical space in order to remain compliant.  To be honest, the first two bullets would be the same as above with respect to advertising via social media:

  • How do you plan to use social media?  To build community and encourage engagement, for marketing purposes, customer service or all of the above?
  • What social media channels do you plan to have a presence on?  Where are your patients or people you are targeting spending time?  Facebook, twitter, Instagram, etc.?
  • Will your advertising be branded, unbranded, or both?  With limited characters available, defining this is vital when developing ads.
  • We strongly recommend having a separate budget for boosting Facebook posts from the rest of the more “traditional” online advertising that is ad based.

A well thought out social media policy, advertising plan, and content strategy can be the difference between a successful program (define success any way you want) and one that sputters and doesn’t result in the KPI’s you are looking for.  Leveraging the power of social media & digital advertising for community building, customer service, as part of a CRM program, and/or for more general advertising can be incredibly powerful and efficient if executed as part of a well thought out plan.

Facebook and Rare Diseases by the numbers

Is Facebook Where It’s At For Rare Diseases?

Rare diseases by the numbers:   7,000 different types of rare diseases 30 million people in the US living with…

Tags: , , , , , , ,

Facebook Stickers

More Robust Facebook Behavioral Targeting

There’s a lot more going on these days on Facebook than the ability to dislike a status update.  Facebook recently…

Tags: , , , , , , , ,

SEM Reality Check

Time for a Digital Marketing Reality Check

Here’s the scenario:  you spend months writing content for a new product or service launch; you develop display, PPC, and…

Tags: , , , , ,

Google logo

Google Shakes up Adwords – No More Special Treatment for Pharma Ads

Google is making some big-ish changes to Adwords specifically affecting the pharmaceutical industry.  The first change will undo the process…

Tags: , , , , ,

Facebook Changes CPC Calculation

What’s in a Name–a Facebook Page Name?

Facebook page names and usernames are often overlooked or not given as much attention as the more obvious profile picture…

Tags: , ,


A Search Engine To Help Diagnose Rare Diseases

If you are trying to diagnose a rare disease, plugging symptoms into Google will probably not be very helpful. In…

Tags: , , , ,

FindZebra: Rare Disease Search Engine

Physicians are trained to arrive at a medical diagnosis by starting with the potential causes that are most common. The…


FDA logo

FDA Letter Mentions Internal Site Search

We recently reviewed this FDA warning letter sent on January 29, 2013 to Medical Doctors Research (MDR), a nutritional supplement…


Google’s New Medication Knowledge Graph in Search Results

There have been some big changes in Google search results for pharmaceutical keywords in the last few weeks. Google has…


Google’s Knowledge Graph & Pharma

On May 16, 2012, Google released a change to the way search results pages are designed. They call this new…


Symptom Search with Dr. Google

In February Google announced a new enhancement to their search results for health symptoms. We have known for a long…


Three Google Innovations and Changes Pharma Needs to Know About

Google has been an important part of the health research process for patients and healthcare providers for many years. This…


Google Analytics Makes Changes in SEO Keyword Reporting

This week Google announced that it is making a change to how Google Analytics (GA) reports keyword level data. Google…


dog with a long tail

Are You Missing the Opportunity with Long-Tail Search?

Although the vast majority of time spent online is spent on long-tail sites — or sites with an overall reach…


What Pharma Marketers Need to Know About Google Instant

On September 8, Google Instant was launched, showing search results as the user types the query. You don’t have to…



Why Search Matters More for Rare Disorders

Pamela Todd, Content Strategist at Siren Interactive, contributes this post: Search matters — especially when it comes to healthcare.  The…


J&J Going For Niche Markets

In an October 6th Advertising Age article titled “Small Brands Could Be J&J’s Next Big Thing,” the journalist reported that…


Pharma photo by Steven Brown under Creative Commons license

WebMD Ad Slowdown Annnouncement: Beginnings of a Trend?

On Wednesday WebMD Health Corp. lowered its financial guidance for 2008, citing a softening ad marketplace. Analysts on Wednesday expressed…


Play by the Rules, SEO in Wikipedia

Wikipedia is fast becoming one of the top reference resources for many who are searching for information on a particular…


The Power of Niche

Back in 2003, Jakob Nielsen was noticing the importance of niche sites. He observed that a niche site might not…


Can Anyone Design a Website?

Recently I overheard a client at a eMarketing conference say “anyone can design a website”. In this world of commoditized…



Social Networking Health Sites

Examples of how the web is changing healthcare practices abound. Here are some examples of sites that are using the…


Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com